This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Osiris Therapeutics Inc (OSIR)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 2.21M 2.42M 1.85M 1.66M
Receivables 34.26M 22.72M 3.06M 728.00K
Inventories 10.92M 1.93M 1.28M 767.00K
Other Current Assets 0.00 91.00K 0.00 0.00
Total Current Assets 95.94M 84.11M 39.04M 51.42M
Property, Plant & Equipment, Gross 7.18M 6.05M 5.56M 5.23M
Accumulated Depreciation & Depletion 5.09M 4.15M 3.45M 2.77M
Property, Plant & Equipment, Net 2.09M 1.90M 2.11M 2.46M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 95.00K 243.00K 317.00K 392.00K
Total Non-Current Assets 2.18M 7.99M 2.43M 2.86M
Liabilities & Shareholder Equity
Total Assets 98.12M 92.10M 41.46M 54.27M
Accounts Payable 8.85M 4.84M 5.00M 4.69M
Short Term Debt 45.00K 45.00K 44.00K 0.00
Other Current Liabilities 0.00 57.00K 0.00 0.00
Total Current Liabilities 10.57M 10.79M 5.04M 8.02M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 3.59M 355.00K 369.00K 430.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 3.59M 355.00K 531.00K 430.00K
Total Liabilities 14.16M 11.15M 5.57M 8.46M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 83.96M 80.95M 35.89M 45.82M
Common Par 35.00K 34.00K 33.00K 33.00K
Additional Paid In Capital 287.52M 282.70M 279.27M 278.09M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -203.54M -201.75M -243.39M -232.33M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -54.00K -33.00K -20.00K 20.00K
Total Capitalization 83.96M 80.95M 35.89M 45.82M
Total Equity 83.96M 80.95M 35.89M 45.82M
Total Liabilities & Stock Equity 98.12M 92.10M 41.46M 54.27M
Total Common Shares Outstanding 34.35M 34.12M 32.88M 32.83M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 34.26M 33.31M 32.86M 32.82M
Diluted Weighted Shares Outstanding 34.26M 33.31M 32.86M 33.12M
Number of Employees 211 70 59 54
Number of Part-Time Employees 6 5 5 3

OSIR Osiris Therapeutics Inc

Chart of OSIR

Analysts Ratings for OSIR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 2 2 2
Moderate Buy 0 0 0 0
Hold 1 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

OSIR Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs